Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity.
about
Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interactionAbsence of MERS-CoV antibodies in feral camels in Australia: Implications for the pathogen's origin and spreadMERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseMERS coronavirus: diagnostics, epidemiology and transmission.MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012.Lack of middle East respiratory syndrome coronavirus transmission from infected camels.Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infectionMERS-CoV in Upper Respiratory Tract and Lungs of Dromedary Camels, Saudi Arabia, 2013-2014High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea.A phylogenetically distinct Middle East respiratory syndrome coronavirus detected in a dromedary calf from a closed dairy herd in Dubai with rising seroprevalence with age.Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016No Serologic Evidence of Middle East Respiratory Syndrome Coronavirus Infection Among Camel Farmers Exposed to Highly Seropositive Camel Herds: A Household Linked Study, Kenya, 2013.Vaccines for the prevention against the threat of MERS-CoV.MERS-CoV at the Animal-Human Interface: Inputs on Exposure Pathways from an Expert-Opinion Elicitation.MERS-coronavirus: From discovery to intervention.Inclusion of MERS-spike protein ELISA in algorithm to determine serologic evidence of MERS-CoV infection.Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014-2015.ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice.Middle-East respiratory syndrome coronavirus: Is it worth a world panic?Absence of MERS-Coronavirus in Bactrian Camels, Southern Mongolia, November 2014.Absence of Middle East Respiratory Syndrome Coronavirus in Camelids, Kazakhstan, 2015.An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus.Diversity of Middle East respiratory syndrome coronaviruses in 109 dromedary camels based on full-genome sequencing, Abu Dhabi, United Arab Emirates.Middle East respiratory syndrome.Reported Direct and Indirect Contact with Dromedary Camels among Laboratory-Confirmed MERS-CoV Cases
P2860
Q28073640-B629CBD1-ABE6-4F6A-81D3-5B5C1399372FQ33718283-1C1DB032-6B7D-4E39-A0AF-FA3605DA0655Q33908067-84D1779F-99C8-4245-A565-E1D079384ABEQ34468689-07E07A23-B502-4983-96C0-9DCAC4EB2A5AQ34506268-04E15D35-BC7A-4D9C-848F-9FD385DBC1D3Q34641572-E65156DA-9675-472B-8AD2-E6A439F28893Q35158287-03CA2AD9-7D6B-4503-BAEC-7B4011FE4D94Q35229655-533EBE50-F606-45BE-80B6-762124252AC2Q35641110-30A05F6E-6139-48E4-A71B-2CCD73112764Q35780285-14F1D3C2-F66C-4D60-AAF2-8A3C60512D78Q35860307-16B6CF91-0A9E-40D5-A32B-092E5D04B4B4Q36353976-6117E55D-0EB2-4FF0-9741-2C2718F53810Q36468664-8396E36C-3667-4A1D-A9F9-58049699C381Q37708530-27C287AB-6762-40C6-BD9A-E1B587F92408Q38673951-3B18F65C-FC41-4FDD-9E10-7A5D8B6F08D3Q38778044-7437079C-62FC-44EC-A4D9-6429559C3021Q39269092-CE712680-61DF-40DE-95B6-8F348521A635Q39374922-A079023B-3DC3-448B-A1F7-C38B4C07E175Q40041686-A39E184E-2F65-44D3-8FFC-953711CDEFEEQ40152026-D45DB0BA-9F18-4B2F-9A61-5F2EBC6018D4Q40173497-CE4EFD7F-32D0-408D-B69F-3F657F91D843Q41048989-3A6D01A6-86EC-4791-9DC6-453C71B7AF57Q42406943-0D67F93D-707D-4084-973E-422D920D2C55Q42591039-4591BC29-51D3-427C-9E40-6109C297DD9AQ47132991-C8BC76AF-8BCB-4605-AC68-5B6FD4D30709Q47133617-C136485B-4929-4EB5-B7E5-6F0C615FFC3FQ51011540-91730E1B-EC62-43CC-ABFF-93A9C470F472Q56557909-E5E70959-9BDE-4B52-9994-C8CE2C16909B
P2860
Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Seroepidemiology of Middle Eas ...... risation of assay specificity.
@ast
Seroepidemiology of Middle Eas ...... risation of assay specificity.
@en
type
label
Seroepidemiology of Middle Eas ...... risation of assay specificity.
@ast
Seroepidemiology of Middle Eas ...... risation of assay specificity.
@en
prefLabel
Seroepidemiology of Middle Eas ...... risation of assay specificity.
@ast
Seroepidemiology of Middle Eas ...... risation of assay specificity.
@en
P2093
P2860
P921
P1433
P1476
Seroepidemiology of Middle Eas ...... risation of assay specificity.
@en
P2093
M G Hemida
P2860
P577
2014-06-12T00:00:00Z